As for FV G1691A and FII G20210A mutations, we observed a definite trend toward an increased probability of thrombosis in patients with these mutations relative to patients with the mentioned mutations without thrombosis (9.1 versus 3.0 and 4.5 versus 0.8 at p = 0.09, respectively).
← all excerpts
Role of Genetic Thrombophilia Markers in Thrombosis Events in Elderly Patients with COVID-19.
1
—
—